Press release
June 25, 2026
Regeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
Regeneron Pharmaceuticals, Inc. (REGN)
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2026 financial and operating results on Thursday, July 30, 2026, before the U.S. financial markets open.